(Q42916434)

11 November 2017

The ralationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973988

11 August 2022

1 reference

M. W. Orr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973988

11 August 2022

D. J. Boullin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973988

11 August 2022

language of work or name

English

0 references

publication date

1 October 1976

1 reference

PMC publication ID

1428938

full work available at URL

11 November 2017

https://europepmc.org/articles/PMC1428938

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973988

https://europepmc.org/articles/PMC1428938?pdf=render

11 August 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973988

British Journal of Clinical Pharmacology

11 August 2022

published in

1 reference

11 November 2017

3

1 reference

11 November 2017

5

1 reference

11 November 2017

925-928

1 reference

Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites

11 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428938

Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine

27 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428938

The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets

27 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428938

Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamine

27 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1976.TB00648.X

Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1976.TB00648.X

The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/973988

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1976.TB00648.X

1 reference

11 November 2017

1 reference

PMC publication ID

1428938

11 November 2017

1 reference

PMC publication ID

1428938